The light-dark regimen and cancer development

Neuroendocrinology Letters

Volumn 23, Issue SUPPL. 2, 2002, Pages 28-36

  Anisimov, Vladimir N ^a  

^a N N PETROV RESEARCH INSTITUTE OF ONCOLOGY   (Russian Federation)

Author keywords

Cancer; Cancer prevention; Light deprivation; Light at night; Melatonin; Pineal gland

Indexed keywords

ANDROGEN; ANTINEOPLASTIC AGENT; CYCLOPHOSPHAMIDE; CYTOSTATIC AGENT; DEXAMETHASONE; DIENESTROL; DIMETHYLBENZ[A]ANTHRACENE; MELATONIN; METHYLNITROSOUREA; RAS PROTEIN; TAMOXIFEN; THIOTEPA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; BLINDNESS; BREAST CARCINOGENESIS; CANCER EPIDEMIOLOGY; CANCER RISK; CONTROLLED STUDY; DRUG ACTIVITY; FEMALE; HORMONE INHIBITION; HUMAN; HUMAN CELL; LIGHT DARK CYCLE; LIGHT EXPOSURE; MOUSE; NIGHT WORK; NONHUMAN; PINEAL GLAND FUNCTION; PINEALECTOMY; RAT; REVIEW; RODENT; SHIFT WORKER;

EID: 0036335879     PISSN: 0172780X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (101)

1. Cancer burden in the year 2000. The global picture
2. Die Lebensdauer von Fliegen unter dem Einfluss von Zeitverschiebungen
3. The effect of different light regimes on sult life span in Drosophila melanogaster is partly nediated through reproductive output
4. Experimental Bases of Treatment of Mastopathy with Iodine Microdoses
5. Experimental Models of Endocrine Gynecological Diseases
6. Effect of hypothalamo-pituitary lesions induced by constant illumination on development of induced mammary tumors in rats
7. Light deprivation, electromagnetic fields and mammary carcinogenesis
8. The relationship between electromagnetic field and light exposure to melatonin and breast cancer risk: A review of the relevant literature
9. Effect of continuous light on the incidence of 9,10-dimethyl-1,2-benzanthracene induced mammary tumors in female Holtzman rats
10. Circadian disruption and breast cancer
11. Melatonin and the Mammalian Pineal Gland
12. Pineal melatonin: Cell biology of its synthesis and of its physiological interactions
13. Residental magnetic fields, light-at-night, and nocturnal urinary 6-suLfatoxymelatonin concentration in women
14. Night shift work, Light at night, and risk of breast cancer
15. Rotating night shifts and risk of breast cancer in women participating in the nurses' health study
16. Incidence of cancer among Finnish airline cabin attendants., 1967-92
17. Incidence of breast cancer in Norwegian female radio and telegraph operators
18. Increased breast cancer risk among women who work predominantly at night
19. Risk of breast cancer in female flight attendants: A population-based study (Ice-land)
20. Role of pineal gland in aetiology and treatment of breast cancer
21. Breast cancer and use of electric power: Experimental studies on the melatonin hypothesis
22. Light in the built environment: Potential role of circadian disruption in endocrine disruption and breast cancer
23. Aging in the hypothalmic-hypophyseal-ovarian axis in the rat
24. Follicular Cysts of the Ovary and Dyshormonal Tumors
25. Blastomogenesis in persistent-estrus rats
26. Carcinogenesis and Aging
27. Hypothalmic mechanisms of ageing and of specific age patholgy-I. Sensitivity threshold of hypothalamopituary complex to homeostatic stimuli in the reproductive system
28. Development, Aging and Disease. A New Rationale for an Intervention Strategy
29. Gonadotropin secretion during aging in women: Review article
30. Effect of light regime and melatonin on the development of spontaneous mammary tumors in HER-2/neu transgenic mice is related to a downregulation of HER-2/neu gene expression
31. Trends in photophysiology concepts
32. Environmental light and DMBA-induced rat mammary tumors
33. Influence of environmental light and melatonin upon mammary tumour induction
34. Influence of light 9,10-dimethylbenz(a) anthracene on rat ovarian steroidogenesis: Neutral steroids
35. Infleunce of light and 9,10-dimethylbenz(a)- anthracene on rat ovarian steroidogenesis: Phenolic steroids
36. Effect of melatonin on the mammary gland morphology, DNA synthesis, hormone profiles and incidence of mammary cancer in rats
37. The effect of infection, hormonal environment, and genetic constitution on mammary tumor induction in rats by 7,12-dimethylbenz(a)anthracene
38. An overview on the neuroendocrine regulation of experimental tumor growth by melatonin and its analogues and the therapeutic use of melatonin in oncology
39. Effect of dark adaptation on carcinogenesis and refficacy of treatment DMBA-induced mammary tumor
40. Experimental Bases for Use of Artificaial Photoregimen for Breast Cancer Treatment in Kazakhstan
41. Oncostatic signaling by the pineal gland and melatonin in the control of breast cancer
42. The pineal: An oncostatic gland
43. Influence of pineal function on the initiation and growth of hormone-dependent breast tumors. Possible mechanisms
44. Profound bilateral blindness and the incidence of breast cancer
45. Reduced cancer incidence among the blind
46. Visual impairment and cancer: A population-based cohort study in Finland
47. Inverse association between breast cancer incidence and degree of visual impairment in Finland
48. Melatonin and mammary pathological growth
49. In vitro effects of melatonin on tumor cells
50. Melatonin inhibition of MCF-7 human breast cancer cell growth: Influence on cell proliferation rate
51. Effects of melatonin on cancer: Studies on MCF-7 human breast cancer cells in culture
52. Is melatonin really an in vitro inhibitor of human breast cancer cell proliferation in vitro
53. Melatonin modulation of estrogen receptor expression in MCF-7 human breast cell
54. Melatonin blocks the stimulatory effects of prolactin on human breast cancer cell growth in culture
55. Circadian rhythms of basic fibroblast growth factor (bFGF), epidermal growth factor (EGF), insulin-Like growth factor-1.(IGF-1), insulin-like growth factor binding protein-3 (IGFBP-3), cortisol, and melatonin in cancer
56. Correlation of anti-tumor activity of pineal and hypothalamic extracts, melatonin and sygetin in mouse transplantable mammary tumor
57. Effect of pinealectomy and melatonin on mammary tumor growth in Sprague-Dawley rats under different conditions of lighting. 3
58. Effect of melatonin on mammary carcinogenesis in intact and pinealectomized rats in varying photoperiods
59. Chemoprevention by melatonin and combined melatonin-tamoxifen therapy of second generation nitroso-methylurea-induced mammary tumour in rats
60. Combination of melatonin and tamoxifen as a chemoprophylaxis against N-nitroso-N-methylurea-induced rat mammary tumors
61. Influence of chronic melatonin on 9,10-dimethyl-1,2-benzanthrazene-induced mammary tumors in female Holtzman rats exposed to continuous light
62. Inhibitory effects of the pineal hormone melatonin and underfeeding during the promotion phase of 7,12-dimethylbenz[a]-anthracene-(DMBA)-induced mammary tumorigenesis
63. Suppressive effect by melatonin on different phases of 9,10-dimethyt-1,2-benzathracene (DMBA)-induced rat mammary gland carcinogenesis
64. Melatonin inhibition and pinealectomy enhancement of 7,12-dimethylbenz[a]anthracene-induced mammary tumors in the rat
65. Host factors affecting the growth of carcinogen-induced rats mammary carcinomas: A review and tribute to Charles Benton Huggins
66. Pineal melatonin inhibition of tumor promotion in the N-nitroso-N-methylurea model of mammary carcinogenesis: Potential involvement of antiestrogenic mechanisms in vivo
67. Effects of melatonin on N-nitroso-N-methylurea-induced carcinogenesis in rats and mutagenesis in vitro (Ames test and COMET assay)
68. A possible modulatory influence of melatonin on representative phase I and II drug metabolizing enzymes in 9,10-dimethyl-benzanthracene induced rat mammary tumorigenesis
69. Differential effect of melatonin on early and advanced passages of a DMBA-induced mammary carcinoma in the female rat
70. Melatonin, a suppressor of spontaneous murine mammary tumors
71. Melatonin increases both life span and tumor incidence in female CBA mice
72. Effect of melatonin on mammary gland lesions in transgenic mice overexpressing N-ras proto-oncogene
73. Effect of melatonin and linolenic acid on mammary cancer in transgenic mice with c-neu breast cancer oncogene
74. Modulation of cancer endocrine therapy by melatonin: A phase II study of tamoxifen plus melatonin in metastatic breast cancer patients progressing under tamoxifen alone
75. Efficacy of melatonin in the immunotherapy of cancer using interteukin-2
76. Melatonin cancer therapy
77. Effect of the mammary carcinogen 7,12-dimethyLbenz[a]anthracene on pineal melatonin biosynthesis, secretion and peripheral metabolism
78. Pineal melatonin synthesis and secretion during induction and growth of mammary cancer in female rats
79. Hepatic hydroxytation of melatonin in the rat is induced by phenoobarbital and 7,12-dimethylbenz[a]anthracene - Implications for cancer etiotogy
80. The modulation of melatonin in tumor-bearing animals: Underlying mechanisms and possible significance for prognosis
81. The validity of melatonin as an oncostatic agent
82. The pineal and its hormones in the control of reproduction in mammals
83. Daily meLatonin administration to middle-aged male rats suppresses body weight, intraabdominal adiposity, and plasma leptin and insulin independent of food intake and total body fat
84. Modulation of the estrogen response pathway in human breast cancer cells by melatonin
85. Modulatory effects of metatonin on genotoxic response of reference mutagens in the Ames test and the comet assay
86. Melatonin reduces gamma radiation-induced primary DNA damage in human blood lymphocytes
87. Reactive oxygen species, DNA damage, and carcinogenesis: Intervention with melatonin
88. Polyunsaturated fatty acids, melatonin, and cancer prevention
89. Melatonin as a chronobiotic/anticancer agent: Cellular, biochemical, and molecular mechanisms of action and their, implications for circadian-based cancer therapy
90. Pathways through which a regimen of melatonin and retinoic acid induced apoptosis in MCF-7 human breast cancer cells
91. Melatonin and the immune system: Therapeutic potential in cancer, viral diseases, and immunodeficiency states
92. Pineal indoles stimulate the gene expression of immunomodulating cytokynes
93. Effect of light/dark regimen on N-nitrosoethylurea-induced transplacental carcinogenesis in rats
94. Effect of melatonin and physiological epiphysectomy on the development of spontaneous endometrial carcinoma in BDII/Han rats
95. The tumor promoting effect of constant light exposure on diethylnitrosamine-induced hepatocarcinogenesis in rats
96. Melatonin and RZR/ROR receptor ligand CGP 52608 induce apoptosis in the murine colonic cancer
97. In vitro effects of melatonin on cell proliferation in a colon adenocarcinoma line
98. Melatonin and colon carcinogenesis: Inhibitory effects of melatonin on development of intestinal tumors induced by 1,2-dimethyLhydrazine in rats
99. Melatonin and colon acrcinogenesis
100. Inhibitory effect of melatonin on 7,12-dimethylbenz [a]anthracene-induced carcinogenesis of the uterine cervix and vagina in mice and mutagenesis in vitro